Apparent mineralocorticoid excess syndrome in a Brazilian boy caused by the homozygous missense mutation p.R186C in the HSD11B2 gene.

作者: Fernanda Borchers Coeli , Lúcio Fábio Caldas Ferraz , Sofia H. V. de Lemos-Marini , Sumara Zuanazi Pinto Rigatto , Vera Maria Santoro Belangero

DOI: 10.1590/S0004-27302008000800012

关键词:

摘要: The apparent mineralocorticoid excess syndrome (AME) is a rare autosomal recessive disorder due to the deficiency of 11beta-hydroxysteroid dehydrogenase type 2 enzyme (11beta-HSD2). 11beta-HSD2 enzyme, encoded by HSD11B2 gene, metabolizes active cortisol in cortisone. Mutations on gene affect activity leading an cortisol, which causes its inappropriate access receptor. Therefore, will bind human maps chromosome 16q22 and consists five exons encoding protein 405 amino acids. We present here clinical molecular studies Brazilian boy who was born pre-term after oligodramnious pregnancy. He diagnosed as having AME at age 26 months. His parents are second cousins. Molecular characterization revealed homozygous mutation p.R186C. patient described case HDS11B2 reported patients with AME.

参考文章(33)
E. Rusvai, A. Náray-Fejes-Tóth, A new isoform of 11 beta-hydroxysteroid dehydrogenase in aldosterone target cells. Journal of Biological Chemistry. ,vol. 268, pp. 10717- 10720 ,(1993) , 10.1016/S0021-9258(18)82044-0
C.R.W. Edwards, D. Burt, M.A. Mcintyre, E.R. De Kloet, P.M. Stewart, L. Brett, W.S. Sutanto, C. Monder, LOCALISATION OF 11β-HYDROXYSTEROID DEHYDROGENASE—TISSUE SPECIFIC PROTECTOR OF THE MINERALOCORTICOID RECEPTOR The Lancet. ,vol. 332, pp. 986- 989 ,(1988) , 10.1016/S0140-6736(88)90742-8
Perrin C. White, Tomoatsu Mune, Anil K. Agarwal, 11β-Hydroxysteroid Dehydrogenase and the Syndrome of Apparent Mineralocorticoid Excess Endocrine Reviews. ,vol. 18, pp. 135- 156 ,(1997) , 10.1210/EDRV.18.1.0288
R C Wilson, M D Harbison, Z S Krozowski, J W Funder, C H Shackleton, H M Hanauske-Abel, J Q Wei, J Hertecant, A Moran, R E Neiberger, Several homozygous mutations in the gene for 11 beta-hydroxysteroid dehydrogenase type 2 in patients with apparent mineralocorticoid excess. The Journal of Clinical Endocrinology and Metabolism. ,vol. 80, pp. 3145- 3150 ,(1995) , 10.1210/JCEM.80.11.7593417
Zygmunt Krozowski, The 11β-hydroxysteroid dehydrogenases: functions and physiological effects Molecular and Cellular Endocrinology. ,vol. 151, pp. 121- 127 ,(1999) , 10.1016/S0303-7207(98)00256-1
P.M Stewart, A Gupta, M.C Sheppard, C.B Whorwood, A.J Howie, D.V Milford, Z.S Krozowski, Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11β-hydroxysteroid dehydrogenase type 2 gene The Lancet. ,vol. 347, pp. 88- 91 ,(1996) , 10.1016/S0140-6736(96)90211-1
Maria I. New, David S. Geller, Francesco Fallo, Robert C. Wilson, Monogenic low renin hypertension Trends in Endocrinology and Metabolism. ,vol. 16, pp. 92- 97 ,(2005) , 10.1016/J.TEM.2005.02.011
Z. S. Krozowski, J. W. Funder, Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity Proceedings of the National Academy of Sciences of the United States of America. ,vol. 80, pp. 6056- 6060 ,(1983) , 10.1073/PNAS.80.19.6056
A. Li, R. Tedde, Z.S. Krozowski, A. Pala, K.X.Z. Li, C.H.L. Shackleton, F. Mantero, M. Palermo, P.M. Stewart, Molecular Basis for Hypertension in the “Type II Variant” of Apparent Mineralocorticoid Excess American Journal of Human Genetics. ,vol. 63, pp. 370- 379 ,(1998) , 10.1086/301955